Overview

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Status:
Completed
Trial end date:
2015-06-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with romosozumab increases bone mineral density in Japanese women with postmenopausal osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Amgen